| abstract |
The present invention provides compositions comprising tolerized immunostimulatory particles (TIMPs) and methods of using and manufacturing the TIMPs. In particular, carrier polymers are conjugated by covalent bonds with antigenic peptides prior to particle formation, which allows for precise control of particle size and antigen encapsulation (e.g., for use in inducing induction of immunological tolerance). |